Aristo Bio-Tech and Lifescience Past Earnings Performance
Past criteria checks 2/6
Aristo Bio-Tech and Lifescience has been growing earnings at an average annual rate of 17.1%, while the Chemicals industry saw earnings growing at 15.2% annually. Revenues have been growing at an average rate of 4.4% per year. Aristo Bio-Tech and Lifescience's return on equity is 11.6%, and it has net margins of 1.6%.
Key information
17.1%
Earnings growth rate
11.7%
EPS growth rate
| Chemicals Industry Growth | 17.7% |
| Revenue growth rate | 4.4% |
| Return on equity | 11.6% |
| Net Margin | 1.6% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How Aristo Bio-Tech and Lifescience makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 2,451 | 39 | 37 | 0 |
| 31 Dec 23 | 2,334 | 37 | 49 | 0 |
| 30 Sep 23 | 2,216 | 36 | 63 | 0 |
| 30 Jun 23 | 2,197 | 36 | 60 | 0 |
| 31 Mar 23 | 2,179 | 36 | 58 | 0 |
| 31 Mar 22 | 1,658 | 14 | 54 | 0 |
| 31 Mar 21 | 1,672 | 11 | 36 | 0 |
| 31 Mar 20 | 2,012 | 10 | 41 | 0 |
| 31 Mar 19 | 2,017 | 28 | 51 | 0 |
Quality Earnings: ARISTO has high quality earnings.
Growing Profit Margin: ARISTO's current net profit margins (1.6%) are lower than last year (1.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ARISTO's earnings have grown by 17.1% per year over the past 5 years.
Accelerating Growth: ARISTO's earnings growth over the past year (9.4%) is below its 5-year average (17.1% per year).
Earnings vs Industry: ARISTO earnings growth over the past year (9.4%) did not outperform the Chemicals industry 10.9%.
Return on Equity
High ROE: ARISTO's Return on Equity (11.6%) is considered low.